These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 34498777)

  • 21. Benefice and pitfall of direct oral anticoagulants in very high-risk myeloproliferative neoplasms.
    Herbreteau L; Papageorgiou L; Le Clech L; Garcia G; James C; Pan-Petesch B; Couturaud F; Gerotziafas G; Lippert E; Ianotto JC
    Thromb Res; 2022 Aug; 216():25-34. PubMed ID: 35689962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
    Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of direct oral anticoagulants for the treatment of venous thromboembolism in the oncology population.
    Hedvat J; Howlett C; McCloskey J; Patel R
    J Thromb Thrombolysis; 2018 Nov; 46(4):483-487. PubMed ID: 30191357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.
    Malec K; Broniatowska E; Undas A
    Lupus; 2020 Jan; 29(1):37-44. PubMed ID: 31757182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
    Brodie MM; Newman JC; Smith T; Rockey DC
    Am J Med; 2018 May; 131(5):573.e9-573.e15. PubMed ID: 29175237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients.
    Christen JR; Bertolino J; Jean E; Camoin L; Ebbo M; Harlé JR; Schleinitz N; Sarlon G; Bernit E
    Hemoglobin; 2019; 43(4-5):296-299. PubMed ID: 31724442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism.
    Howe Z; Naville-Cook C; Cole D
    J Thromb Thrombolysis; 2019 Feb; 47(2):280-286. PubMed ID: 30449001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery.
    Siscos SM; Neill BC; Singh AH; Hocker TLH
    J Am Acad Dermatol; 2021 Feb; 84(2):425-431. PubMed ID: 33045293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy and safety of oral anticoagulants for the treatment of venous thromboembolism in the patients with different renal functions: a systematic review, pairwise and network meta-analysis.
    Su X; Yan B; Wang L; Cheng H; Chen Y
    BMJ Open; 2022 Feb; 12(2):e048619. PubMed ID: 35190410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.
    van Es N; Coppens M; Schulman S; Middeldorp S; Büller HR
    Blood; 2014 Sep; 124(12):1968-75. PubMed ID: 24963045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry.
    Navarro-Almenzar B; Cerezo-Manchado JJ; Caro-Martinez C; García-Candel F; Flores Blanco PJ; Ruiz GE; Andreu Cayuelas JM; Montoya FA; Cascales A; Lova Navarro A; García Alberola A; Andrés Pascual Figal D; Bailen Lorenzo JL; Manzano-Fernández S
    Curr Med Res Opin; 2019 Dec; 35(12):2035-2041. PubMed ID: 31335222
    [No Abstract]   [Full Text] [Related]  

  • 36. A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants.
    Cohen AT; Hill NR; Luo X; Masseria C; Abariga SA; Ashaye AO
    Int J Cardiol; 2018 Oct; 269():174-181. PubMed ID: 30037626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?
    Voigtlaender M; Langer F
    Hamostaseologie; 2017 Oct; 37(4):241-255. PubMed ID: 28508916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients.
    Kalani C; Awudi E; Alexander T; Udeani G; Surani S
    Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series.
    DeCamillo D; Haymart B; Barnes GD
    J Thromb Thrombolysis; 2022 Apr; 53(3):601-606. PubMed ID: 34559367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.